The purpose of this study is to determine whether accelerated treatment with custom-made compression sleeve is more effective than standard procedure in the treatment of mild and moderate arm lymphedema secondary to primary cancer treatment.
Use of a custom-made compression sleeve is an initial treatment of mild and moderate arm lymphedema secondary to primary breast cancer treatment. The compression sleeve improves the flow of lymph fluid out of the arm, reduces the swelling, and prevents progression of the lymphedema in the future. Early intervention is recommended though early is not well-defined in literature. The purpose of this study is to evaluate reduction of excess limb volume and changes in arm disability and clinical symptoms in accelerated treatment with compression sleeve compared to standard treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
84
Device: Compression garments worn for a minimum of six hours per day
Educational information and recommendations about lymphedema and skin care. Instruction in physical exercises to enhance the lymph flow
Aarhus University Hospital, Fysioterapi- og Ergoterapisfdelingen
Aarhus, Aarhus, Denmark
RECRUITINGChange of excess limb volume (ELV)
ELV in the affected arm compared to the non-affected arm. ELV described as both absolute volume in ml and relative volume in percent
Time frame: 8 weeks follow-up
Changes in arm disability
Measured with Disabilities of Arm, Shoulder, and Hand (DASH)
Time frame: 8 weeks follow-up
Changes in subjective symptoms (pain, tension, and heaviness)
Time frame: 8 weeks follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.